COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080152654A1
SERIAL NO

11761940

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of methods of using siRNAs targeting VEGF including an siRNA defined by SEQ ID NO: 77 and SEQ ID NO: 78 to stabilize visual acuity in a subject, to inhibit choroidal neovascularization lesions, to treat age-related macular degeneration, to treat diabetic macular edema, and to decrease foveal thickness in subjects are disclosed. Additionally, methods of treating age-related macular degeneration and diabetic macular edema by administering combinatorial therapy comprising an siRNA targeting VEGF and a non-siRNA VEGF antagonist are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RXI PHARMACEUTICALS CORPORATION1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Reich, Samuel Jotham Miami Beach, FL 26 767

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation